companydata.dkNovo Nordisk North America Operations A/S: Financial statements 2017
CVR: 33761201
Novo Nordisk North America Operations A/S (CVR 33761201) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -2,394,000 compared with DKK -5,342,000 the year before. Equity amounted to DKK 2,666,000. The solvency ratio was 3%.
- Profit/Loss
- -2,394,000 kr.
- Equity
- 2,666,000 kr.
- Total Assets
- 88,670,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -2.4 mio. | 2.7 mio. | - |
| 2016 | - | - | -5.3 mio. | 25.1 mio. | - |
| 2015 | - | - | -5.7 mio. | 40.6 mio. | - |
| 2014 | - | - | -21 t. | 424 t. | - |
| 2013 | - | - | -27 t. | 445 t. | - |
Find more companies like Novo Nordisk North America Operations A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
As of June 1, 2017, Lene Moth Bang has joined the board of directors of Novo Nordisk North America Operations A/S.
As of June 1, 2017, Lars Fruergaard Jørgensen has left the board of directors of Novo Nordisk North America Operations A/S.
Novo Nordisk North America Operations A/S has published its annual report for 2016. The net result was DKK -5,342,000.
About Novo Nordisk North America Operations A/S
Novo Nordisk North America Operations A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2011. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named Novo Nordisk Invest 3 A/S and NOVO NORDISK REGION NORTH AMERICA II A/S. The management consists of Anders Rytter Mikkelsen. The company is owned by NOVO NORDISK A/S. In 2025, the company reported a gross profit of DKK -59,000 and a net result of DKK -74,142,000 compared with DKK -89,167,000 the year before. Equity amounted to DKK 60,045,000.